Report
Log in or create a free account to download
Full Report
Each Venture Philanthropy transaction involves numerous complicated issues: governance, intellectual property ownership and licensing, termination, indemnification, and publication, among others, but the issue that encompasses the most negotiating time by far involves the amount of royalties to be paid by the awardee to the granting charity. The purpose of the series of questions and answers included in this article is to shorten that time, thereby putting the award to work on the underlying research faster, and to look forward to the day when the research is successful and the royalty can be monetized.
Log in or create a free account to download
Full Report
Related Content
-
Milken Institute and Motsepe Foundation Announce Milken-Motsepe Prize in AgriTech Finalists
25 teams to share $250,000 in funding to refine, develop, and demonstrate their breakthrough ideas in Africa Los Angeles and Johannesburg (February 23, 2022) - The Milken Institute and the Motsepe Foundation today announced the 25 teams...Read Article -
Type 1 Diabetes Autoantibody Screening Implementation Roadmap: 2022 REPORT UPDATE
In April 2021, the Milken Institute, with generous funding from the Leona M. and Harry B. Helmsley Charitable Trust, published a report focused on the implementation of type 1 diabetes (T1D) autoantibody screening in the general population...Read Report -
The Reinvention of Prevention: How to Fund and Finance a Pivot to a Prevention-First Healthcare System
As part of the debut of the Milken Institute’s Project Prevent initiative in 2024, the Institute conducted a series of interviews with 35 key stakeholders and experts in health, finance, philanthropy, pensions, and public policy to explore...Read Report -
Stepping off the Sidelines: The Unrealized Potential of Strategic Ultra-High-Net-Worth Philanthropy
The challenges our world is facing today will take a concerted, collaborative effort, and high-impact philanthropists are poised to lead that effort like never before. However, at this moment in time, only 36 percent of the world’s ultra...Read Report11
Hilary McConnaughey Page and Sokol Shtylla -
Biswas Family Foundation Transformative Computational Biology Grant Awardees
The Biswas Family Foundation and the Milken Institute are pleased to announce the five research teams selected to receive funding in the first cycle of the Transformative Computational Biology Grant Program. Almost $14 million has been...Read Article -
Milken Institute report examines Ultra-High Net-Worth Philanthropy, offers recommendations to spur giving
Washington D.C. – June 15, 2020 – The Milken Institute Center for Strategic Philanthropy released a new report analyzing the state of ultra-high-net-worth (UHNW) philanthropy, highlighting that much-needed capital remains accessible but...Read Article -
Glioblastoma Multiforme: A Giving Smarter Guide to Accelerating Research Progress
Glioblastoma Multiforme (GBM) is an aggressive malignant brain tumor involving glial cells of the brain. At the time of this report, nearly 15,000 people were diagnosed with GBM each year in the United States and Europe. The prognosis for...Read Report -
Activating Philanthropic and Business Capital: Strategies to Advance Gun Violence Prevention in the US
Each year, more than 40,000 lives are lost due to firearm-related incidents, with many more suffering injuries that lead to enduring challenges.Read Report -
The Milken Institute Celebrates 25th Global Conference May 1-4
The four-day, in-person event features more than 800 speakers, including government officials, Oscar winners, philanthropists, investors, and more. Los Angeles, CA – May 1, 2022 – Beginning today, the 25th annual Milken Institute Global...Read ArticleImageChad Clinton
Director, Media RelationsChad Clinton is the director of media relations for the Milken Institute. Hired to this role in August 2021, Clinton develops and executes strategies to amplify the Institute’s core messages by generating coverage of its pillar workstreams, experts, and events. -
Roadmap for Investment in Dementia Care
On average, people with Alzheimer’s disease and frontotemporal dementia live six to ten years after diagnosis. People with vascular dementia and Lewy body dementia live on average five to six years after diagnosis. A great deal can and...Read Report11 11
-
New Report by the Milken Institute Details Innovative Financing Solutions to Reinvent Preventative Healthcare in the United Kingdom
27 January 2024 (London, UK)—With a shift towards preventative healthcare needed by both the National Health Service (NHS) and the new United Kingdom (UK) government, innovative financing solutions are critical to ensuring the...Read ArticleImagePaul Guequierre
Director, Strategic CommunicationsPaul Guequierre is the director of strategic communications. In this role, he works to increase the profile of Milken Institute in the media, raise the visibility of issues important to the organization and its stakeholders, and expand the Institute's digital presence. -
Nonprofits: A Growing Force in Drug Development
Shepherding a drug from discovery to the market is a complex process that involves many actors. The process often begins with academic researchers making a breakthrough discovery in the lab and ends with pharmaceutical companies running...Read Report11Kirstie Keller and Cara Altimus, PhD